News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
McAvoy David R.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/04/2023 |
4
| McAvoy David R. (Gen Counsel, CCO, & Secretary) has filed a Form 4 on Fresh Tracks Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 7,358 shares
@ $0.9798, valued at
$7.2k
Exercised 20,000 restricted stock units
@ $0 |
|
| 01/26/2023 |
4
| McAvoy David R. (Gen Counsel, CCO, & Secretary) has filed a Form 4 on Fresh Tracks Therapeutics, Inc.|
Txns:
| Granted 20,000 restricted stock units
@ $0 |
|
| 05/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/21/2020 |
4
| McAvoy David R. (General Counsel and CCO) has filed a Form 4 on Brickell Biotech, Inc.|
Txns:
| Bought 16,526 shares
@ $0.8298, valued at
$13.7k
Bought 6,000 shares
@ $0.8398, valued at
$5k
|
|
| 09/17/2020 |
4
| McAvoy David R. (General Counsel and CCO) has filed a Form 4 on Brickell Biotech, Inc.|
Txns:
| Granted 350,000 options to buy
@ $0.8, valued at
$280k
|
|
| 06/22/2020 |
4
| McAvoy David R. (General Counsel and CCO) has filed a Form 4 on Brickell Biotech, Inc.|
Txns:
| Bought 30,435 shares
@ $0
Bought 30,435 warrants
@ $1.25, valued at
$38k
|
|
| 03/18/2020 |
4
| McAvoy David R. (General Counsel and CCO) has filed a Form 4 on Brickell Biotech, Inc.|
Txns:
| Granted 25,000 restricted stock units
@ $1.54, valued at
$38.5k
|
|
| 09/09/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/21/2018 |
4
| McAvoy David R. (General Counsel) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Disposed/sold 2,119 shares
@ $24, valued at
$50.9k
Disposed/sold 23,750 shares
@ $24, valued at
$570k
Disposed/sold 37,500 options to buy
@ $2.96, valued at
$111k
|
|
| 11/15/2018 |
3
| McAvoy David R. (General Counsel) has filed a Form 3 on ENDOCYTE INC |
|
|